P666: 1 YEAR RESULTS OF DASATINIB 70MG/DAY VERSUS 100MG/DAY IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE(CML-CP):A PROSPECTIVE RANDOMIZED CONTROLLED STUDY.
Dan Yu,
Hui Cheng,
Jingming Guo,
Rui Jiang,
Youshan Zhang,
Chucheng Wan,
Jun Qin,
Guolin Yuan,
Shiming Chen,
Zhuangzhi Yang,
Junbin Hu,
Yicheng Zhang,
Weiming LI
Affiliations
Dan Yu
1 Wuhan No.1 Hospital Department of Hematology, Department of Hematology, Wuhan, China
Hui Cheng
2 Wuhan No.1 Hospital, Department of Hematology, Wuhan, China
Jingming Guo
3 Yichang Central People’s hospital, Department of Hematology, yichang, China
Rui Jiang
4 Jingmen No.1 people’s hospital, Department of Hematology, Jinmen, China
Youshan Zhang
5 Jingzhou No.1 People’s hospital, Department of Hematology, Jingzhou, China
Chucheng Wan
6 SHiyan taihe hospital, Department of Hematology, Shiyan, China
Jun Qin
7 Shiyan people’s hospital, Department of Hematology, shiyan
Guolin Yuan
8 Xiangyang central hospital, Department of Hematology, xiangyang, China
Shiming Chen
9 Huangshi central hospital, Department of Hematology, Huangshi, China
Zhuangzhi Yang
10 Suizhou Central Hospital corresponding, Department of Hematology, suizhou, China
Junbin Hu
11 Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Department of Hematology, Wuhan, China
Yicheng Zhang
12 Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology, Department of Hematology, Wuhan, China
Weiming LI
11 Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Department of Hematology, Wuhan, China
